Latest news with #PortnoyLawFirm
Business Upturn
13-05-2025
- Business
- Business Upturn
Geron Corporation Investors: Please contact the Portnoy Law Firm to recover your losses. May 12 2025 Deadline to file Lead Plaintiff Motion.
LOS ANGELES, May 12, 2025 (GLOBE NEWSWIRE) — Investors can contact the law firm at no cost to learn more about recovering their losses The Portnoy Law Firm advises Geron Corporation ('Geron' or the 'Company') (NASDAQ: GERN) investors of a class action representing investors that bought securities between February 28, 2024 and February 25, 2025, inclusive (the 'Class Period'). Acadia Healthcare investors have until May 12 2025 to file a lead plaintiff motion. Investors are encouraged to contact attorney Lesley F. Portnoy, by phone 310-692-8883 or email: [email protected], to discuss their legal rights, or click here to join the case. The Portnoy Law Firm can provide a complimentary case evaluation and discuss investors' options for pursuing claims to recover their losses. The Geron class action lawsuit alleges that, throughout the Class Period, defendants made false and/or misleading statements and/or failed to disclose that: (i) defendants falsely suggested they possessed reliable information regarding Geron's projected revenue outlook and anticipated growth, while downplaying risks related to seasonality and broader macroeconomic conditions; (ii) in reality, Geron's optimistic portrayals of Rytelo's launch success and growth potential were overstated, as seasonality, existing competition, and the ongoing monitoring requirements had a far greater impact on patient uptake than defendants had indicated; and (iii) Rytelo lacked sufficient market awareness to achieve meaningful penetration, preventing Geron from capitalizing on the purportedly significant unmet need for the drug, particularly among first-line patients and those outside academic medical settings. The lawsuit further claims that, on February 26, 2025, Geron announced its financial results for the fourth quarter of fiscal year 2024, revealing that Rytelo's growth had stagnated over the prior months. The company attributed the slowed growth to seasonality, competitive pressures, limited awareness of Rytelo, and the burden associated with the drug's required monitoring. Following this announcement, Geron's stock price fell by more than 32%, according to the complaint. Please visit our website to review more information and submit your transaction information. The Portnoy Law Firm represents investors in pursuing claims against caused by corporate wrongdoing. The Firm's founding partner has recovered over $5.5 billion for aggrieved investors. Attorney advertising. Prior results do not guarantee similar outcomes. Lesley F. Portnoy, CA and NY Bar [email protected] 310-692-8883
Associated Press
16-04-2025
- Business
- Associated Press
Sana Biotechnology, Inc. Investors: Please contact the Portnoy Law Firm to recover your losses. May 20, 2025 Deadline to file Lead Plaintiff Motion.
Investors cancontactthe law firm at no cost to learn more about recovering their losses LOS ANGELES, April 16, 2025 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Sana Biotechnology, Inc. ('Sana' or the 'Company') (NASDAQ: SANA) investors of a class action representing investors that bought securities between March 17, 2023 to November 4, 2024, inclusive (the 'Class Period'). SANA investors have until May 20, 2025 to file a lead plaintiff motion. Investors are encouraged to contact attorney Lesley F. Portnoy, by phone 310-692-8883 or email: [email protected], to discuss their legal rights, or click here to join the case. The Portnoy Law Firm can provide a complimentary case evaluation and discuss investors' options for pursuing claims to recover their losses. The complaint alleges that, during the Class Period, Defendants made materially false and/or misleading statements and/or failed to disclose that: (i) Sana was at significant risk of lacking sufficient capital to sustain its current operations and continue development of one or more of its product candidates; (ii) the Company's programs—SC291 in oncology, SC379, and SG299—were less promising than Defendants had represented to investors; (iii) to conserve cash and prioritize its more promising pipeline assets, Sana was likely to reduce funding for, or discontinue, SC291 in oncology, SC379, and SG299, and significantly cut its workforce; (iv) as a result, Defendants overstated the Company's financial ability to maintain its operations and advance its product pipeline; and (v) consequently, Defendants' public statements were materially false and/or misleading throughout the Class Period. Please visit our website to review more information and submit your transaction information. The Portnoy Law Firm represents investors in pursuing claims against caused by corporate wrongdoing. The Firm's founding partner has recovered over $5.5 billion for aggrieved investors. Attorney advertising. Prior results do not guarantee similar outcomes. Lesley F. Portnoy, Esq. Admitted CA and NY Bar [email protected] 310-692-8883 Attorney Advertising
Associated Press
16-04-2025
- Business
- Associated Press
Canopy Growth Corporation Investors: Please contact the Portnoy Law Firm to recover your losses. June 3, 2025 Deadline to file Lead Plaintiff Motion.
Investors cancontactthe law firm at no cost to learn more about recovering their losses LOS ANGELES, April 16, 2025 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Canopy Growth Corporation ('Canopy' or the 'Company') (NYSE: ATKR) investors of a class action representing investors that bought securities between May 30, 2024 and February 6, 2025, inclusive (the 'Class Period'). Canopy Growth Corporation investors have until June 3, 2025 to file a lead plaintiff motion. Investors are encouraged to contact attorney Lesley F. Portnoy, by phone 310-692-8883 or email: [email protected], to discuss their legal rights, or click here to join the case. The Portnoy Law Firm can provide a complimentary case evaluation and discuss investors' options for pursuing claims to recover their losses. On February 7, 2025, Canopy Growth released its financial results for the third quarter of fiscal year 2025, falling short of consensus estimates. The Company reported a 400 basis point decline in gross margin, bringing it down to 32%. Canopy attributed the decrease to increased costs associated with the launch of its Claybourne infused pre-rolls in Canada, as well as higher indirect costs related to its Storz & Bickel vaporizer devices. Please visit our website to review more information and submit your transaction information. The Portnoy Law Firm represents investors in pursuing claims against caused by corporate wrongdoing. The Firm's founding partner has recovered over $5.5 billion for aggrieved investors. Attorney advertising. Prior results do not guarantee similar outcomes. Lesley F. Portnoy, Esq. Admitted CA and NY Bar [email protected] 310-692-8883 Attorney Advertising
Associated Press
20-03-2025
- Business
- Associated Press
Bitfarms Investors: Company Investigated by the Portnoy Law Firm
Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, March 20, 2025 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Bitfarms ('Bitfarms' or 'the Company') (NASDAQ: BITF) investors that the firm has initiated an investigation into possible securities fraud and may file a class action on behalf of investors. Bitfarms investors that lost money on their investment are encouraged to contact Lesley Portnoy, Esq. Investors are encouraged to contact attorney Lesley F. Portnoy, by phone 310-692-8883 or email: [email protected], to discuss their legal rights, or click here to join the case. The Portnoy Law Firm can provide a complimentary case evaluation and discuss investors' options for pursuing claims to recover their losses. On December 9, 2024, after market close, Bitfarms issued a press release titled 'Bitfarms Announces Restatement of Previously Issued Financial Statements.' The company disclosed that its consolidated financial statements for the fiscal years 2022 and 2023 contained a material error related to the classification of proceeds from digital asset sales and would need to be restated. Additionally, Bitfarms identified an accounting error concerning the redemption of warrants in 2023, prompting further adjustments. Following this announcement, Bitfarms' stock price dropped 6% on December 10, 2024. Please visit our website to review more information and submit your transaction information. The Portnoy Law Firm represents investors in pursuing claims against caused by corporate wrongdoing. The Firm's founding partner has recovered over $5.5 billion for aggrieved investors. Attorney advertising. Prior results do not guarantee similar outcomes. Lesley F. Portnoy, Esq. 310-692-8883 Attorney Advertising
Associated Press
04-02-2025
- Business
- Associated Press
Integral Ad Science Holding Corp. Investors: Please contact the Portnoy Law Firm to recover your losses. March 31, 2025 Deadline to file Lead Plaintiff Motion.
Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, Feb. 04, 2025 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Integral Ad Science Holding Corp. ('IAS' or the 'Company') (NASDAQ: IAS) investors of a class action representing investors that bought securities between March 2, 2023, and February 27, 2024, inclusive (the 'Class Period'). IAS investors have until March 31, 2025 to file a lead plaintiff motion. Investors are encouraged to contact attorney Lesley F. Portnoy, by phone 310-692-8883 or email: [email protected], to discuss their legal rights, or click here to join the case. The Portnoy Law Firm can provide a complimentary case evaluation and discuss investors' options for pursuing claims to recover their losses. The complaint claims that, during the Class Period, the defendants misrepresented or failed to disclose several key issues, including: (i) that IAS was facing a new, significant trend of heightened competitive pricing pressures, forcing the company to lower prices to address weaker demand and slower revenue growth; (ii) that IAS's pricing strategy was no longer advantageous and it could not maintain or raise prices as previously expected; (iii) that pricing had become a crucial factor in differentiating IAS from competitors, which was necessary to secure major renewals and new contracts; (iv) that the risks of increased competition leading to pricing pressures or forcing price changes had already materialized; and (v) as a result, IAS's public statements during this period were materially false and misleading. Please visit our website to review more information and submit your transaction information. The Portnoy Law Firm represents investors in pursuing claims caused by corporate wrongdoing. The Firm's founding partner has recovered over $5.5 billion for aggrieved investors. Attorney advertising. Prior results do not guarantee similar outcomes. 310-692-8883 Attorney Advertising
